Supporting UK scientists
Through its funding programmes, the Royal Society works in partnership with universities and industry, both within the UK and internationally, to support outstanding researchers and invest in the future of science.
We help more than 1600 of the UK's best scientists every year to develop the ideas that will improve the quality of our lives. Our support ranges from postdoctoral level to senior professorships, and grants for a variety of purposes ranging from conference travel to the modernisation of laboratories. Our international grants programme enables high calibre UK scientists to initiate collaborations, form partnerships, and exchange ideas and experience with the world's leading researchers.
Royal Society discussion meetings are interdisciplinary international conferences on innovative areas of science, engineering and technology. Leaders in the subject come from all over the world to present the latest advances and the meetings are published in Philosophical Transactions of the Royal Society.
The Royal Society has been publishing since 1660 and today we publish seven peer-reviewed international journals covering: biological and physical sciences; history and philosophy of science; and cross-disciplinary research at the interface between the physical and life sciences.
In 2009 the Society launched an entirely new venture with the purchase of Chicheley Hall in Buckinghamshire to create a residential centre for the advancement of science. The Kavli Royal Society International Centre will promote scientific research and will enable the extension of the wide range of events already hosted by the Society in London.
The Royal Society Enterprise Fund provides early-stage funding for innovative new businesses emerging from the science base in the UK and overseas. Run on a commercial basis, the Fund leverages the Society's unique advantages, including its outstanding technical and scientific network, its extensive policy activity and flexible time horizons for investment. In order to ensure sustainability, the Fund is evergreen, with financial gains returned to the Fund for reinvestment in future innovative science.